title: High prevalence of antiretroviral drug resistance mutations in HIV-1 non-B subtype strains from African children receiving antiretroviral therapy regimen according to the 2006 revised WHO recommendations.
authors.forename: Jean-Chrysostome
authors.initials: JC
authors.lastname: Gody
authors.forename: Charlotte
authors.initials: C
authors.lastname: Charpentier
authors.forename: Olivia
authors.initials: O
authors.lastname: Mbitikon
authors.forename: Ali
authors.initials: A
authors.lastname: Si-Mohamed
authors.forename: Jérome
authors.initials: J
authors.lastname: LeGoff
authors.forename: Gérard
authors.initials: G
authors.lastname: Grésenguet
authors.forename: Laurent
authors.initials: L
authors.lastname: Bélec
mesh_terms: D000293:Adolescent; D000349:Africa; D044966:Anti-Retroviral Agents / Q000008:administration & dosage / Q000494:pharmacology*; D002648:Child; D002675:Child, Preschool; D024882:Drug Resistance, Viral / Q000235:genetics; D005260:Female; D005838:Genotype; D015658:HIV Infections / Q000188:drug therapy* / Q000821:virology; D015497:HIV-1 / Q000145:classification / Q000187:drug effects* / Q000235:genetics*; D006801:Humans; D007223:Infant; D008297:Male; D009154:Mutation; D010349:Patient Compliance; D015995:Prevalence; D019562:Viral Load; D014944:World Health Organization
chemical_list: D044966:Anti-Retroviral Agents